[Mental health after treatment with elexacaftor/tezacaftor/ivacaftor in end-stage cystic fibrosis].

Background: Studies showed significant physical improvement after starting elexacaftor/tezacaftor/ivacaftor (ETI). However, some patients reported new mental health symptoms.

Aim: This study explores the impact of ETI on end-stage cystic fibrosis patients, focusing on mental health.